Trials / Conditions / Human Immunodeficiency Virus Infections

Human Immunodeficiency Virus Infections

11 registered clinical trials studyying Human Immunodeficiency Virus Infections.

Status	Trial	Sponsor	Phase
Terminated	A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human NCT03563742	Janssen Research & Development, LLC	Phase 3
Completed	Safety, PK and PD Study of ABX464 in Untreated HIV Patients NCT02452242	Abivax S.A.	Phase 2
Completed	A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT NCT00727597	Georgetown University	Phase 3
Completed	Attitudes and Beliefs and the Steps of HIV Care NCT00749840	M.D. Anderson Cancer Center	—
Completed	Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministere NCT00358917	Abbott	Phase 3
Unknown	Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatmen NCT00332306	Tuberculosis Research Centre, India	Phase 3
Completed	Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration NCT00262522	Abbott	Phase 3
Completed	Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid NCT00888446	International AIDS Vaccine Initiative	Phase 2
Completed	An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study NCT00294918	EMD Serono	Phase 2 / Phase 3
Completed	Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associat NCT00294164	EMD Serono	Phase 2 / Phase 3
Unknown	Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis NCT00376012	Tuberculosis Research Centre, India	Phase 3